GVHD: An Overview of Graft vs Host Disease Post Hematopoietic Stem Cell Transplant
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-08/McElfresh%20APP%20Live%20CI%20140.jpg?itok=7P2_dfIz)
Megan McElfresh, PA-C, provides an overview of the pathophysiology, diagnosis, prevention, and treatment of graft vs host disease post hematopoietic stem cell transplant.
Category
- Advanced Practice Provider
Format
- Self-Paced, Online Courses
Credits
- 1.00 NCPD/CNE
- 1.00 Participation
Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-12/Weiner%20R2P%20CI%20140px.jpg?itok=p6IIGd_F)
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-12/Hu%20R2P%20CI%20140px.jpg?itok=7HngEHgN)
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
Multidisciplinary/Multimodality Management of Locally Recurrent Rectal Cancer - SPOC
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-11/Guillem%20R2P%20CI%20Blue%20140.jpg?itok=BFvUUkjv)
Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR
- 1.00 Participation
Clinical Updates in Breast Oncology - SPOC
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-11/Ray%20R2P%20CI%20White%20140.jpg?itok=6-jB3vTr)
Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-08/Zeidner%20R2P%20Live%20CI%20140.jpg?itok=FK2LA7ma)
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 CTR Category A
- 1.00 NCPD/CNE
- 1.00 Participation
Cardiovascular Toxicities of Cancer Therapies
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-08/Jensen%20R2P%20Live%20CI%20140.jpg?itok=nqjGtk0Q)
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
Genitourinary Cancer Management in North Carolina
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2024-01/Tan%20R2P%20CI%20140.jpg?itok=_fX4YXB0)
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 AMA PRA Category 1 Credit™
- 1.25 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
Sarcoma Management in North Carolina: Updates for 2023
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2022-12/Woodcock%20R2P%20CI%20140px.jpg?itok=RGKltaYR)
Mark Woodcock gives a broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
Lymphoma Management in North Carolina: Updates for 2023
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2023-01/Grover%20R2P%20CI%20140px.jpg?itok=NCWPhln_)
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR Category A
- 1.00 NCPD/CNE
- 1.00 Participation